-
Piramal Invests $32M to Expand Michigan Facility
contractpharma
December 09, 2020
Piramal Pharma Solutions (PPS) is investing $32 million to expand its facility in Riverview, MI with additional capacity and new capabilities for the development and manufacture of Active Pharmaceutical Ingredients (APIs).
-
Bora Establishes First HQ in North America
contractpharma
December 08, 2020
Bora Pharmaceuticals, an international contract development and manufacturing organization, has selected Mississauga as the location for its first manufacturing facility and corporate headquarters in North America.
-
AGC Biologics Expands Copenhagen Facility
contractpharma
December 07, 2020
AGC Biologics is increasing the production capacity of its Copenhagen facility. The company will construct a new building on land adjacent to its current Copenhagen site, adding production floors with 2000L single-use bioreactors, labs and office space.
-
KBI Biopharma Expands U.S. Ops
contractpharma
December 03, 2020
KBI Biopharma, Inc., a JSR Life Sciences company, established a new commercial manufacturing facility in Research Triangle Park, NC. KBI expects the $150 million, 140,000-sq.-ft. facility to be operational by 1Q22.
-
Divi’s Laboratories commence construction of facility near Kakinada
expresspharma
December 03, 2020
The company will be investing about Rs 1500 crores for the implementation of the facility.
-
Camfil to Build New Manufacturing Facility in Arkansas
americanpharmaceuticalreview
December 02, 2020
Camfil Air Pollution Control (APC) has announced the construction of a new manufacturing facility in Jonesboro to replace its previous building that was destroyed by a tornado in March.
-
UK PM visits Wockhardt facility in North Wales
expresspharma
December 02, 2020
The UK Government has reserved one fill and finish production line at Wockhardt UK for its exclusive use for 18 months in order to guarantee the supply of vaccines required to fight against COVID-19.
-
AGC Biologics to Expand Biopharmaceutical CDMO Capacity
prnasia
December 01, 2020
AGC Biologics announced that it will increase the production capacity of its Copenhagen facility. AGC Biologics will construct a new building on land adjacent to its current Copenhagen site, adding production floors with 2000L single-use bioreactors ...
-
ApiJect Systems Approved for $590 Million Loan
contractpharma
November 25, 2020
Supports building a U.S.-based facility with surge capacity to produce up to 3 billion single-dose prefilled plastic injectors per year.
-
Samsung Biologics Breaks Ground on 'Super Plant'
contractpharma
November 25, 2020
When completed, the CDMO says it will be the world's largest bio-manufacturing facility.